Open original FDA record ↗Recall record
- FDA identifier
- Z-1876-2016
- Company in FDA record
- Leica Microsystems, Inc.
- FDA record creation date
- Jun 1, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Testing of retained units indicated that Lot numbers of CDX2 and RCC indicated are not stable up to the expiry date on the product labeling.
Source facts
- Action
- An Urgent: Medical Device Recall Notification dated 4/5/2016 was sent to consignees with the affected lots of CDX2 and RCC marker. The customers were notified of the problems as well as the following actions to be taken by the consignees: Do not use or continue to use the reagent lots listed above, as they have the potential to result in inadequate tissue staining and lead to weak or false negative pathology results. Appropriately destroy any unused or partially used affected lots of the reagent Complete the attached Recall Notification Acknowledgement Form that this action has been undertaken. The firm also request that the notification is passed to all those within their organization who need to be aware of this issue. The firm requests consignees to return the completed acknowledgement form to LMGRA@Leica-Microsystems.com to receive credit for affected lots that have been destroyed by the consignees laboratory.
- Initiated
- 2016-04-05
- Root cause
- Nonconforming Material/Component
- Terminated
- 2017-11-30
- Distribution
- Distributed in the following states AR, CA, CT, FL, ID, IL, IN, MT, OH, PA, TN and TX, and in Canada.
- Recall number
- Z-1876-2016
- Recall status
- Terminated
- CDRH record ID
- 145003
- FDA record created
- 2016-06-01
- Recall event number
- 73802